A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer
Clinical trial NCT07358377 · RECRUITING
Trial details
- NCT number
- NCT07358377
- Sponsor
- Atridia Pty Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-15
- Primary completion
- 2027-04-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.